Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $48.0000 (-2.04%) ($47.5000 - $50.0000) on Mon. Apr. 1, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.53% (three month average) | RSI | 65 | Latest Price | $48.0000(-2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.8% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -7.765% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.765% (StdDev 15.53%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $48.7(-1.44%) | 10 Day Moving Average | $48.36(-0.74%) | 20 Day Moving Average | $46.69(2.81%) | To recent high | -48.1% | To recent low | 140% | Market Cap | $945m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |